Literature DB >> 12379924

Inclusion complex formation of captopril with alpha- and beta-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamic studies.

Yoichi Ikeda1, Sohko Motoune, Toshikazu Matsuoka, Hidetoshi Arima, Fumitoshi Hirayama, Kaneto Uekama.   

Abstract

The inclusion complex formation of alpha-cyclodextrin (alpha-CyD), beta-cyclodextrin (beta-CyD), and 2-hydroxylpropyl-beta-cyclodextrin (HP-beta-CyD) with an angiotensin converting enzyme inhibitor, captopril, in aqueous solution was studied by (1)H- and (13)C-nuclear magnetic resonance spectroscopies, including ROESY and GROESY techniques, by kinetic methods and by molecular dynamic calculations. The oxidative degradation of captopril was markedly suppressed in alpha-CyD solutions, whereas beta-CyD and HP-beta-CyD had negligible stabilizing effects. These NMR and kinetic results suggested that alpha-CyD includes preferably the propyl thioalcohol moiety of captopril, depositing the proline moiety outside the cavity. On the other hand, beta-CyD includes a whole molecule of captopril in the cavity, locating the carboxylic acid within the cavity and the terminal thiol moiety outside the cavity. These inclusion structures were supported by molecular dynamic studies. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2390-2398, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379924     DOI: 10.1002/jps.10232

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  2 in total

1.  New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles.

Authors:  Mariangela de Burgos M de Azevedo; Ljubica Tasic; Juliana Fattori; Fábio H S Rodrigues; Fabiana C Cantos; Leandro P Ribeiro; Vanice de Paula; Danielle Ianzer; Robson A S Santos
Journal:  Int J Nanomedicine       Date:  2011-05-15

2.  Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.

Authors:  Norased Nasongkla; Andy F Wiedmann; Andrew Bruening; Meghan Beman; Dale Ray; William G Bornmann; David A Boothman; Jinming Gao
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.